Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Radiotherapy and Oncology

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2016.10.001PMID 27884510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Diagnostic Value of MR Imaging in Determining the Lymph Node Status of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis.

  2016cited by this paper
• Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

  2016cited by this paper
• Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

  2016cited by this paper
• Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy.

  2016cited by this paper
• Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis

  2015cited by this paper
• Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.

  2015cited by this paper
• Comparative Effectiveness of Intensity-Modulated Versus 3D Conformal Radiation Therapy Among Medicare Patients with Stage III Lung Cancer

  2014cited by this paper
• Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cited by this paper
• Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cited by this paper
• Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.

  2013cited by this paper
• High-dose radiotherapy in inoperable nonsmall cell lung cancer: comparison of volumetric modulated arc therapy, dynamic IMRT and 3D conformal radiotherapy.

  2012cited by this paper
• Intensity-modulated radiotherapy in the treatment of breast cancer.

  2012cited by this paper
• Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

  2012cited by this paper
• Intensity-modulated radiotherapy in the treatment of lung cancer.

  2012cited by this paper
• Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET-CT.

  2012cited by this paper
• Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients

  2012cited by this paper
• Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer.

  2012cited by this paper
• Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.

  2011cited by this paper
• Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.

  2010cited by this paper
• European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer.

  2010cited by this paper
• Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

  2010cited by this paper
• Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.

  2010cited by this paper
• Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.

  2009cited by this paper
• Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.

  2009cited by this paper
• Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis

  2008cited by this paper
• Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).

  2008cited by this paper
• Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

  2008cited by this paper
• A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer

  2007cited by this paper
• Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.

  2007cited by this paper
• Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

  2006cited by this paper
• Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.

  2005cited by this paper
• CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan.

  2005cited by this paper
• Dose-response relationship for radiation therapy of subclinical disease.

  1995cited by this paper

• Isolated nodal failure in stage III non-small-cell lung cancer after proton therapy with or without durvalumab.

  2025cites this paper
• Single isocenter versus dual isocenter treatment using flattening filter‐free and jaw‐tracking volumetrically modulated arc therapy for boot‐shaped lung cancer: Evaluation of dosimetric and feasibility

  2024cites this paper
• IMRT in the treatment of locally advanced or inoperable NSCLC in the pre-durvalumab era: clinical outcomes and pattern of relapses, experience from the Oscar Lambret Center

  2023cites this paper
• Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

  2022cites this paper
• Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)

  2021cites this paper
• PET/CT in radiation oncology.

  2019cites this paper
• Strahlentherapie beim nicht metastasierten Lungenkarzinom

  2018cites this paper
• The role of functional imaging in lung cancer

  2018cites this paper
• Radiotherapy dose escalation in locally advanced NSCLC - The limits of conventional radiochemotherapy.

  2018cites this paper
• Image-guided adaptive radiotherapy in patients with locally advanced non-small cell lung cancer: the art of PET.

  2018cites this paper
• Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial.

  2017cites this paper
• Incidental nodal irradiation in locally advanced non-small cell lung cancer treated with involved-field IMRT

  2017cites this paper